n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
New Clinical Research Site Increases Access to Clinical Trials in Poland and Helps Local Communities and Doctors Participate in Clinical Research
BOSTON, March 18, 2024–(BUSINESS WIRE)–Care Access, a global clinical trial site company helping to drive the future of medicine, has opened its new study facility in Warsaw, Poland. The company’s expansion into Poland reinforces its commitment to accessing clinical trials globally through its cutting-edge style of bringing clinical trials to where they are needed.
In recent years, Care Access has been actively involved in clinical trials across Europe and today, by building a new facility in Warsaw, Care Access is further expanding its European facilities with the aim of implementing its state-of-the-art study features, such as its network-based system. Discovery program, on-demand sites, and cellular search site infrastructure. These features have been shown to increase recruitment for studies by tailoring to the unique composition of each network and offering more convenient tactics for participating in clinical trials.
“Poland plays a critical role in making medicine a reality,” said Rupi Bancil, senior vice president of global research operations and expanding access to healthcare. “The Warsaw center will have access to complex medical examinations and study opportunities for communities around the world. Poland. “
Collaborating with local clinicians is a key technique to enable Care Access to improve access to clinical trials in more communities. With a centralized team of study professionals, equipment, infrastructure, and processes, Care Access takes on much of the administrative and logistical burden so that medical partners can spend more time focusing on their patients.
In the past, Care Access has expanded its global network of study sites through the acquisition of IBPClin in Brazil in 2022 and the status quo of its first Canadian study site in Cape Breton in 2023. The addition of the Warsaw site strengthens Care Access’ global network of study sites, enabling the company to test in multiple healing spaces and address emerging global fitness needs.
About to Care
Care Access is a global corporate clinical trials site that helps drive the future of medicine. With a global network of more than two hundred study sites, Care Access supports studies conducted through many leading biopharmaceutical companies. In addition to its proven track record, Care Access has a track record of having the highest number of recruited sites in the world, partnering with communities of new study participants and establishing a high-quality study site infrastructure to expand access to clinical trials and increase representation.
For study sponsors, Care Access offers 3 main facilities: (1) a global network of study sites, (2) community-based assessments to expand the scope of a study, and (3) staffing, area extension, and on-demand education. Facilities for all studios. Sites in a studio.
To learn more about active studies in Care Access or how Care Access is helping sponsors reach their enrollment and representation goals, www. careaccess. com.
See the businesswire. com edition: https://www. businesswire. com/news/home/20240318427054/en/
Contactos
Jose Ohmedia@careaccess. com 202-970-6885